In creating functional scales, it has been recognized that there is a typical order of progressive functional loss [ 1].
Here we explore recent bioengineering advances in creating functional blood macro and microvessels, particularly featuring stem cells as a seed source.
We have recently embarked on cardiac tissue engineering work due to the significant promise of this research direction in creating functional cardiac tissue for modeling of heart diseases and for generation a new organ that may be transplantable.
This defined human-based NMJ system is one of the first steps in creating functional in vitro systems and will play an important role in understanding NMJ development, in developing high information content drug screens and as test beds in preclinical studies for spinal or muscular diseases/injuries such as muscular dystrophy, Amyotrophic lateral sclerosis and spinal cord repair.
Cells, biomaterials, and bioreactors are the three components of the standard tissue-engineering paradigm, and the success in creating functional engineered tissues lies in the integration of these components.
The discussion today focused largely on empowering mods to do what they need to do, which should have a knock-on effect in creating functional communities.
The size of these nanoparticles facilitates their use in engineering of surfaces and in creating functional nanostructures [ 3].
We propose that the AAR encoded by tri-nt SSRs might have a crucial role in creating functional variability of gene regulation.
If the repeat-driven mechanisms currently active in creating functional CTCF-binding events were also active in the common mammalian ancestor, then ancestral expansions would eventually become shared binding events in descendant species, such as our study species.
In general, however, our analysis of the p53 REs confirms the observations made earlier [ 36] and provides an additional evidence that the CG → TG transition was a driving force in creating functional p53 sites embedded in Alu repeats at hot spots 10 and 150 (Boxes A/A' in Figure 2).
